Clinical trial
Magnetic Resonance Assessment of Victoza Efficacy in the Regression of Cardiovascular Dysfunction In Type 2 Diabetes Mellitus
NCT01761318 is registered in ClinicalTrials.gov with Leiden University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Magnetic Resonance Assessment of Victoza Efficacy in the Regression of Cardiovascular Dysfunction In Type 2 Diabetes Mellitus
- Lead sponsor
- Leiden University Medical Center
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 30, 2013
- Completion date
- March 31, 2016
- Enrollment
- 50 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cardiovascular disease, diabetes mellitus type 2, diastolic dysfunction, fatty liver, metabolic syndrome